Datavant Highlights Advanced Privacy Risk Modeling for Sensitive Health Data

According to a recent LinkedIn post from Datavant, the company is spotlighting new analytical work on re-identification risks in real-world health data, with a focus on U.S. veterans. The post references a blog by a senior data scientist examining how veteran status can act as a quasi-identifier under HIPAA Expert Determination and where conventional de-identification techniques may be insufficient.

The LinkedIn post indicates that the analysis covers how veteran status might be inferred from clinical, payer, and facility data, as well as how linkage attacks can elevate re-identification risk. It also notes a population-based modeling approach using American Community Survey data to quantify individual-level risk and proposes targeted mitigation strategies intended to reduce that risk while preserving data utility.

For investors, the post suggests Datavant is positioning its technology and expertise around more granular, risk-based privacy protection, which is increasingly critical as real-world data adoption grows. Strengthening capabilities in HIPAA-compliant de-identification for sensitive cohorts like veterans could enhance Datavant’s value proposition to pharma, providers, and payers, potentially supporting pricing power, customer retention, and regulatory resilience in the health data connectivity market.